摘要
目的:初步探讨清肺合剂对中青年及老年原发性肺癌患者的临床疗效及生存状况。方法:选择2003年1月—2008年12月间收治的肺癌病人中,连续服用清肺合剂3年以上的原发性肺癌患者120例,分别入组中青年组和老年组,分析其临床特点构成和生存状况。结果:120例肺癌患者中,64.17%的中晚期肺癌患者的生存率达3年以上,高于同类文献报道。中青年组和老年组的临床构成比中吸烟、病理类型、治疗方式、TNM分期等因素具有统计学意义。清肺合剂对青年人肺癌和非青年人肺癌的咳嗽、咳痰、痰血、胸痛等有效缓解率达70%以上,对两组人群的临床症状改善情况无明显差异。结论:清肺合剂在改善患者的临床症状,提高生活质量等方面已得到证实,但对于肺癌手术后及放、化疗后的长期预防治疗及是否有延长生存期的作用,还有待进一步证实。
Objective ： To observe the clinical effect and survival state of youth and elderly primary lung cancer patients treated with Qingfei Mixture. Methods ：120 patients with primarily lung cancer and treated with Qingfei Mixture between January 2003 and December 2008 were selected and assigned to youth group and elderly group. These patients clinical characteristics and survival state were analyzed. Results：64.17% of 120 patients exceeded 3 -year survival time,which was higher than that of the congenial literature. Cigarette, pathological type,treatment and TNM stage in the youth group had statistical significance differences compared with those of the elder group. Qingfei Mixture can improve clinical symptoms of primarily lung cancer,and the rate was more than 70%. Conclusion：It was proved that Qingfei .Mixture can improve clinical symptom, enhance quality of life, but the effects of prevention, treatment and extension of the survival period on lung cancer patients after operation, radiotherapy or chemotherapy are need to be further proved.
出处
《中华中医药学刊》
CAS
2014年第2期325-327,共3页
Chinese Archives of Traditional Chinese Medicine
基金
浙江省中医药防治重大疾病攻关计划(2011ZGG001)
关键词
清肺合剂
原发性肺癌
生存状况
临床疗效
Qingfei Mixture
primary lung cancer
survival state
clinical effect
